awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26768259-8EF34C21-551E-439B-AC30-49CAA7D5FC6F
Q26768259-8EF34C21-551E-439B-AC30-49CAA7D5FC6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768259-8EF34C21-551E-439B-AC30-49CAA7D5FC6F
Review of vedolizumab for the treatment of ulcerative colitis
P2860
Q26768259-8EF34C21-551E-439B-AC30-49CAA7D5FC6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768259-8EF34C21-551E-439B-AC30-49CAA7D5FC6F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3421073cf648caa0251f6cf407c4e70937f2d263
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.